Live Price
Live Volume
Biogen Market Segments
After Hours
| Open | $218.89 |
|---|---|
| Close | $219.29 |
| Low | $218.89 |
| Low Change | 0.00 (0.00%) |
| High | $219.29 |
| High Change | +0.40 (+0.18%) |
| Range | $0.40 |
| Volume | 254.263K |
| Dollar Volume | $55.76M |
Regular Trading Hours
| Open | $217.68 |
|---|---|
| Close | $219.04 |
| Low | $215.33 |
| Low Change | -2.35 (-1.08%) |
| High | $219.41 |
| High Change | +1.73 (+0.79%) |
| Range | $4.08 |
| Volume | 563.815K |
| Dollar Volume | $123.50M |
Premarket
| Open | $217.00 |
|---|---|
| Close | $217.00 |
| Low | $217.00 |
| Low Change | 0.00 (0.00%) |
| High | $217.98 |
| High Change | +0.98 (+0.45%) |
| Range | $0.98 |
| Volume | 1.9K |
| Dollar Volume | $412.30K |
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $216.01 |
|---|---|
| Close | $216.01 |
| Low | $216.01 |
| Low Change | 0.00 (0.00%) |
| High | $216.01 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 177.254K |
| Dollar Volume | $38.29M |
Regular Trading Hours Yesterday
| Open | $216.41 |
|---|---|
| Close | $216.04 |
| Low | $214.81 |
| Low Change | -1.60 (-0.74%) |
| High | $218.29 |
| High Change | +1.88 (+0.87%) |
| Range | $3.48 |
| Volume | 400.556K |
| Dollar Volume | $86.54M |
Premarket Yesterday
| Open | $217.00 |
|---|---|
| Close | $217.00 |
| Low | $217.00 |
| Low Change | 0.00 (0.00%) |
| High | $217.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 105 |
| Dollar Volume | $22.79K |
Biogen News
1 month agoinvesting.comWolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
2 months agoinvesting.comBiogen beats quarterly estimates as newer drugs fuel growth
2 months agoinvesting.comBiogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradox
2 months agoinvesting.comBiogen stock rises on positive Alzheimer’s drug trial data
2 months agobarrons.comBiogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem
2 months agoinvesting.comWhy is Biogen stock rallying today?
2 months agoinvesting.comTruist upgrades Biogen to Buy on Alzheimer’s, pipeline optimism ahead of key data
2 months agobarrons.comBiogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study Details
2 months agobarrons.comCan Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?
4 months agoinvesting.comBiogen advances Alzheimer’s drug after mid-stage trial results
Biogen Top Trades
Biogen's top trade so far today returned +1.84%, while the top short trade returned -1.22%.
Biogen Moving Averages
| 5 Day Moving Average (SMA5) | $216.44 |
|---|---|
| 10 Day Moving Average (SMA10) | $217.35 |
| 20 Day Moving Average (SMA20) | $217.95 |
| 50 Day Moving Average (SMA50) | $209.88 |
| 100 Day Moving Average (SMA100) | $203.21 |
| 200 Day Moving Average (SMA200) | $192.47 |
Biogen Statistics
| Average Volume (30 Days) | 760.28K |
|---|---|
| P/E Ratio (Current) | 38.26 |
| EPS (Current) | $5.65 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $2.70B |
| Cash Ratio | 0.33 |
| Current Ratio | 1.87 |
| Quick Ratio | 1.26 |
| Debt to Equity | 0.43 |
| Enterprise Value | $38.75B |
| EV to EBITDA | 16.84 |
| EV to Sales | 3.86 |
| Price to Book | 1.69 |
| Price to Cash Flow | 11.09 |
| Price to Free Cash Flow | 11.84 |
| Price to Sales | 3.19 |
| Return on Assets | 0.03% |
| Return on Equity | 0.04% |
Biogen Stock Splits
There have been no stock splits for Biogen (BIIB).
Biogen Dividends
There have been no dividends for Biogen (BIIB).